RIL
RYTM icon

Rothschild Investment LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Rothschild Investment LLC’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
109
+23
+27% +$2.08K ﹤0.01% 1778
2026
Q1 		$7.48K Sell
86
-5
-5% -$486 ﹤0.01% 1844
2025
Q4 		$9.74K Buy
91
+6
+7% +$636 ﹤0.01% 1585
2025
Q3 		$8.58K Sell
85
-20
-19% -$1.86K ﹤0.01% 1502
2025
Q2 		$6.63K Buy
105
+15
+17% +$918 ﹤0.01% 1373
2025
Q1 		$4.77K Buy
90
+25
+38% +$1.39K ﹤0.01% 1459
2024
Q4 		$3.64K Buy
65
+55
+550% +$3.04K ﹤0.01% 1469
2024
Q3 		$524 Buy
10
+5
+100% +$240 ﹤0.01% 2455
2024
Q2 		$205 Hold
5
– – ﹤0.01% 2480
2024
Q1 		$217 Buy
+5
New +$219 ﹤0.01% 1714

Other funds holding RYTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Rothschild Investment LLC's RYTM Position: Q2 2026 in Review

Rothschild Investment LLC increased its Rhythm Pharmaceuticals (RYTM) stake by 27% in Q2 2026, buying an estimated $2.08K and bringing the position to 109 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1778.

Rothschild Investment LLC first reported a position in RYTM in Q1 2024 and has held it in 10 quarters since. 265 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Rothschild Investment LLC held 109 shares of Rhythm Pharmaceuticals worth $12.1K as of Q2 2026.
  • Rothschild Investment LLC bought 23 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $2.08K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1778 holding.
  • Rothschild Investment LLC first reported a position in Rhythm Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 265 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.